Orexo: Zubsolv solidly maintains market share

Redeye Research Update 2021/01/20

Redeye updates the market share data for Zubsolv. Zubsolv maintains market share in terms of prescriptions, number of tablets sold, and dollar value of the total market. This looks sustainable to us.

Download research report

Gergana Almquist

Equity Analyst

Orexo: Zubsolv solidly maintains market share

Redeye Research Update timeStamp 2021/01/20

Mentioned companies

You need to be a Redeye member to access this content

Become a member to:

Redeye Research Update 2021/01/20